New research, led by experts at the University of Nottingham, has found that certain types of medication used to treat ...

Global diabetes rates have surged, particularly in low-resource areas, revealing critical gaps in treatment access and ...

Diabetes is a metabolic disorder that develops when the body is unable to produce or effectively use insulin the hormone ...

The FDA has granted approval to Azurity Pharmaceuticals' nilotinib tablets (Danziten), a novel version of the tyrosine kinase ...

For patients with type 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with ...

The rise in type 2 diabetes cases globally presents opportunities for growth in the market for GLP-1 drugs like Ozempic and ...

The long-term consequences of this metabolic dysfunction are extensive. (Image Credits: Pixabay) Diabetes risk and obesity: ...

Several districts across Nagaland observed World Diabetes Day on Thursday on the theme “Breaking barriers, bridging gaps.” ...

Dr Menon believes that lifestyle modifications are “essential in managing diabetes and preventing complications.” His ...

Diabetic nephropathy, a serious diabetes complication ... lifestyle guidance, and targeted treatments. “Through proactive ...

Diabetes cannot prevent you from getting a policy. You must disclose it as a pre-existing illness, but insurers cannot deny ...

Diabetes and obesity are intertwined health conditions with serious consequences if left unmanaged. Obesity increases the ...